Sign in
4

Changes in Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-25-010973

Options or other derivatives

  • Chief Medical Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ferguson James J. III · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-05 Grant or award : show line 1 in the form Stock Options +60,000 60,000 D
Loading xslF345X05/ownership.xml…